Skip to main content

SEGALL BRYANT & HAMILL, LLC

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1006378 CHICAGO, IL

Position in LKFT

as of Mar 31, 2026 · filed May 22, 2026
Position Value
$12,792,360
-$1,860,379 QoQ
Shares Held
426,412
-4.8% QoQ
Ownership
0.651%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 63% Shared 0% None 37%

Common Shares in LKFT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $322,746,195 across 29 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in LKFT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,792,360 426,412
2025-12-31 $14,652,739 448,096
2025-09-30 $16,876,469 487,196
2025-06-30 $14,025,145 501,077
2025-03-31 $16,364,700 651,461
2024-12-31 $18,861,342 685,867
2024-09-30 $20,315,605 705,648
2024-06-30 $19,801,177 799,079
2024-03-31 $27,950,952 868,042
2023-12-31 $35,557,693 874,728
2023-09-30 $25,497,589 737,991
2023-06-30 $15,912,738 391,361
2023-03-31 $11,568,468 299,391